This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Buspirone

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Of the class azaspirones, unrelated to benzodiazepines but indicated in the short term management of generalised anxiety disorder.

It does not cause sedation or cognitive impairment, probably has low risk of dependence and withdrawal problems (1).

It is not a hypnotic and only affects sleep as underlying anxiety comes under control. It may have antidepressant activity. It does not potentiate the sedative effects of alcohol.

  • in normal doses it does not usually have a marked sedative effect, and people are thought to be less likely to become dependent on buspirone than they are on benzodiazepine medicines. Its action is not fully understood, but this drug appears to work via effects on serotonin receptors in the brain. In this respect it is like an SSRI antidepressant, rather than a benzodiazepine (2)

Reference:

  • Prescribers Journal (1992), 32, 5.
  • Hertfordshire Partnership University NHS Foundation Trust. Buspirone (accessed 11/6/2014).

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.